Dr. Daniel C. Danila, MD
- Medicare services, 2024
- 1,373
- Medicare patients, 2024
- 338
- Part D claims, 2024
- 1,376
- Publications
- 51
- Clinical trials
- 3
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Danila's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Daniel C. Danila is a medical oncologist in New York, New York
Dr. Danila practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Danila's NPI, 1952460172, was assigned on December 6, 2006. Dr. Danila holds Massachusetts license 220779.
- NPI
- 1952460172NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9638221377
- NPI enumeration date
- December 6, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 56
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Daniel C. Danila practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Danila's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Daniel C. Danila is affiliated with 2 sites of care and 3 medical groups
Dr. Danila's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Danila to 2 more medical groups and 1 home health agency, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Daniel C. Danila's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Danila practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +1 more site and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Daniel C. Danila is one of 458 medical oncologists in New York
Medical oncology is Dr. Danila's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Danila is licensed in Massachusetts.
Specialties and state licenses
- Medical oncology, MassachusettsPrimary
Medical oncologists near Dr. Danila
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Daniel C. Danila billed Medicare for 1,373 services in 2024
CMS data shows 1,373 Medicare services from Dr. Danila across 6 procedure codes in 2024, for 338 Medicare patients. Medicare paid $120,894 for them.
Dr. Danila's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 9722024: 1,0094%
- Other services
- 2023: 02024: 364
Where Dr. Danila's Medicare services took place, 2024
- In an office1,32496%
- In a facility494%
Dr. Danila compared with the New York median for medical oncologists, 2024
- Dr. Danila
- New York median
- Medicare services
- 1,373vs 3404.0 times
- Medicare patients
- 338vs 1123.0 times
- Part D claims
- 1,278vs 1309.8 times
Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.
Dr. Danila's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Danila?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Danila and other medical oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Daniel C. Danila treated 338 Medicare patients in 2024, average age 76
CMS counts 338 Medicare patients who saw Dr. Danila in 2024. The largest group is 75 to 84, with 154 patients. 75% of them have cancer, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Danila's median patient age at 75, with 2% women.
Dr. Danila's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Danila's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure73%
- Arthritis46%
- Ischemic heart disease39%
- Diabetes30%
- Chronic kidney disease24%
- Mood disorders21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Danila's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 75
Patient panel by sex, all payers
- Women2%
- Men97%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Daniel C. Danila wrote 1,376 Medicare Part D claims in 2024
In 2024, Dr. Danila wrote 1,376 Medicare Part D claims for 187 patients. 54% of them were for generic drugs. CMS names the drug for 1,278 of them, across 14 drugs with 11 or more claims each, at $6,750,196 in total drug cost. In 2023, CMS named 1,080 claims across 14 drugs.
Dr. Danila's Part D claims by kind of drug, 2024
- Generic737 claims54%
- Brand-name639 claims46%
Dr. Danila's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Danila's Part D claims, 2024
- Opioids2%26 of 1,376 claims
- Antibiotics1%12 of 1,376 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0802024: 1,27818%
Drugs named by CMS: 14 in 2024, 14 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Daniel C. Danila scored 83 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Danila for performance year 2024, reported as part of a group. Dr. Danila accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Danila as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Danila's MIPS scores, performance year 2024
- 83of 100Final score
- 80.9of 100Quality
- 40of 100Improvement Activities
- 65of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Daniel C. Danila has 51 publications on record
Dmand AI links 51 papers to Dr. Danila, published from 2011 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Prostatic Neoplasms, Castration-Resistant, Biomarkers, Tumor and Prostatic Neoplasms. Dr. Danila has published most often in Clin Cancer Res. Dr. Danila's most frequent co-authors are Howard I. Scher, MD, Michael Morris, MD and Wassim Abida, MD, PhD.
Dr. Danila's papers by year, 2016 to 2025
Topics Dr. Danila writes about most
- Prostatic Neoplasms, Castration-Resistant
- Biomarkers, Tumor
- Prostatic Neoplasms
- Neoplastic Cells, Circulating
- Bone Neoplasms
- Neoplasm Metastasis
- Receptors, Androgen
- RNA, Messenger
Dr. Danila's most frequent co-authors
- Howard I. Scher, MD29 shared papers
- Michael Morris, MD11 shared papers
- Wassim Abida, MD, PhD10 shared papers
Recent publications by Dr. Danila
See who Dr. Danila researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Danila works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Daniel C. Danila has worked on 3 clinical trials
Dmand AI links Dr. Danila to 3 clinical trials, 2 of them phase 1 studies. Conditions studied include Rectal Diseases and Colorectal Neoplasms. Biosplice Therapeutics, Inc. sponsors the most, 2.
Clinical trials with Dr. Danila by phase
- 2Phase 1: 2 trials
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Danila's trials
- Rectal Diseases
- Colorectal Neoplasms
Investigators on the most trials with Dr. Danila
- Kerry Roe Schaffer, MD2 shared trials
- Benjamin Adam Weinberg, MD2 shared trials
- Jahan Aghalar, MD1 shared trial
Recent clinical trials with Dr. Danila
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Daniel C. Danila received $71,328 in industry payments from 2016 to 2025
CMS Open Payments shows 111 general payments to Dr. Danila from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Pfizer Inc. paid the most, $15,437. It also lists 7 research payments totaling $6,400 from 2023 to 2025.
General payments to Dr. Danila by program year, 2016 to 2025
General payments to Dr. Danila by kind, 2016 to 2025
- Consulting fees$46,81866%
- Speaker and faculty fees$12,37017%
- Travel and lodging$6,98010%
- Food and beverage$4,1596%
- Honoraria$1,0001%
Companies that paid Dr. Danila the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Daniel C. Danila's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Daniel C. Danila
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Daniel C. Danila's NPI number?
Dr. Daniel C. Danila's NPI number is 1952460172. It was assigned on December 6, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Daniel C. Danila?
Dr. Daniel C. Danila is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Daniel C. Danila practice?
Dr. Danila practices at 1275 York Avenue, New York, NY 10065. Dr. Danila's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Danila to 2 medical groups and 1 home health agency.
What is Dr. Daniel C. Danila's medical license number?
Dr. Danila holds Massachusetts license 220779.
Which hospitals is Dr. Daniel C. Danila affiliated with?
Dr. Danila practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. Daniel C. Danila part of?
Dr. Danila is linked to Memorial Sloan Kettering Cancer Center. Dmand AI links Dr. Danila to 2 more medical groups.
Does Dr. Daniel C. Danila accept Medicare?
Yes. CMS data shows Dr. Danila billed Medicare for 1,373 services in 2024, and Dr. Danila accepts Medicare assignment.
Does Dr. Daniel C. Danila offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Danila as offering telehealth services.
What is Dr. Daniel C. Danila's MIPS score?
Dr. Danila's MIPS final score for performance year 2024 is 83 out of 100, reported as part of a group.
How many Medicare patients does Dr. Daniel C. Danila see?
CMS counts 338 Medicare patients who saw Dr. Danila in 2024, with an average age of 76.
Show 6 more questionsShow fewer questions
What services does Dr. Daniel C. Danila bill to Medicare?
In 2024, Dr. Danila's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).
What drugs does Dr. Daniel C. Danila prescribe most?
In 2024 Medicare Part D data, Dr. Danila's most prescribed drugs by claims were Xtandi, Prednisone and Abiraterone Acetate.
Has Dr. Daniel C. Danila received payments from drug or device companies?
CMS Open Payments shows $71,328 in general payments to Dr. Danila from 16 companies from 2016 to 2025. The largest total came from Pfizer Inc.
How long has Dr. Daniel C. Danila been practicing?
Dr. Danila graduated from medical school in 1996, 30 years ago.
Does Dr. Daniel C. Danila do research?
Dmand AI links 51 publications to Dr. Danila, published from 2011 to 2025. Dr. Danila has worked on 3 clinical trials.
Who does Dr. Daniel C. Danila publish with?
Dr. Danila's most frequent co-authors are Howard I. Scher, MD (29 shared papers), Michael Morris, MD (11 shared papers) and Wassim Abida, MD, PhD (10 shared papers).
Selling to medical oncology practices?
See medical oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card